63
|
257
|
1d4pB |
Crystal structure of human alpha thrombin in complex with 5-amidinoindole-4-benzylpiperidine inhibitor |
65
|
257
|
1d3dB |
Crystal structure of human alpha thrombin in complex with benzothiophene inhibitor 4 |
64
|
287
|
1d6wA |
Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at p1 |
56
|
259
|
1ditH |
Complex of a divalent inhibitor with thrombin |
60
|
288
|
1d9iA |
Structure of thrombin complexed with selective non-electophilic inhibitors having cyclohexyl moieties at p1 |
63
|
257
|
1d3pB |
Crystal structure of human aplha-thrombin in complex with benzo[b]thiophene inhibitor 3 |
54
|
256
|
1de7H |
Interaction of factor xiii activation peptide with alpha-thrombin: crystal structure of the enzyme-substrate complex |
3
|
29
|
1ditL |
Complex of a divalent inhibitor with thrombin |
5
|
28
|
1d3tA |
Crystal structure of human alpha thrombin in complex with benzo[b]thiophene inhibitor 1 |
6
|
28
|
1d3qA |
Crystal structure of human alpha thrombin in complex with benzo[b]thiophene inhibitor 2 |
54
|
259
|
1dm4B |
Ser195ala mutant of human thrombin complexed with fibrinopeptide a (7-16) |
3
|
36
|
1c5nL |
Structural basis for selectivity of a small molecule, s1-binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
52
|
259
|
1c1uH |
Recruiting zinc to mediate potent, specific inhibition of serine proteases |
3
|
36
|
1c5lL |
Structural basis for selectivity of a small molecule, s1-binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
1
|
36
|
1c1wL |
Recruiting zinc to mediate potent, specific inhibition of serine proteases |
3
|
36
|
1c5oL |
Structural basis for selectivity of a small molecule, s1-binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
52
|
259
|
1c4v2 |
Selective non electrophilic thrombin inhibitors with cyclohexyl moieties. |
1
|
36
|
1c1vL |
Recruiting zinc to mediate potent, specific inhibition of serine proteases |
53
|
259
|
1c5lH |
Structural basis for selectivity of a small molecule, s1-binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
56
|
259
|
1c4u2 |
Selective non electrophilic thrombin inhibitors with cyclohexyl moieties. |
50
|
259
|
1c1wH |
Recruiting zinc to mediate potent, specific inhibition of serine proteases |
3
|
36
|
1c1uL |
Recruiting zinc to mediate potent, specific inhibition of serine proteases |
53
|
259
|
1c5oH |
Structural basis for selectivity of a small molecule, s1-binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
53
|
258
|
1c4y2 |
Selective non-electrophilic thrombin inhibitors |
3
|
26
|
1ca8A |
Thrombin inhibitors with rigid tripeptidyl aldehydes |
1
|
27
|
1c4y1 |
Selective non-electrophilic thrombin inhibitors |
57
|
254
|
1bthH |
Structure of thrombin complexed with bovine pancreatic trypsin inhibitor |
2
|
36
|
1c4v1 |
Selective non electrophilic thrombin inhibitors with cyclohexyl moieties. |
53
|
258
|
1ca8B |
Thrombin inhibitors with rigid tripeptidyl aldehydes |
53
|
259
|
1c1vH |
Recruiting zinc to mediate potent, specific inhibition of serine proteases |
4
|
31
|
1bthJ |
Structure of thrombin complexed with bovine pancreatic trypsin inhibitor |
52
|
259
|
1c5nH |
Structural basis for selectivity of a small molecule, s1-binding, sub-micromolar inhibitor of urokinase type plasminogen activator |
3
|
30
|
1c4u1 |
Selective non electrophilic thrombin inhibitors with cyclohexyl moieties. |
2
|
28
|
1bmmL |
Human alpha-thrombin complexed with [s-(r*,r*)]-4-[(aminoiminomethyl)amino]-n-[[1-[3-hydroxy-2-[(2-naphthalenylsulfonyl)amino]-1-oxopropyl]-2-pyrrolidinyl] methyl]butanamide (bms-186282) |
2
|
36
|
1bbrJ |
The structure of residues 7-16 of the a alpha chain of human fibrinogen bound to bovine thrombin at 2.3 angstroms resolution |
3
|
29
|
1ay6L |
Thrombin inhibitor from theonalla, cyclotheanamide-based macrocyclic tripeptide motif |
52
|
259
|
1avgH |
Thrombin inhibitor from triatoma pallidipennis |
3
|
30
|
1bhxA |
X-ray structure of the complex of human alpha thrombin with the inhibitor sdz 229-357 |
3
|
29
|
1b5gL |
Human thrombin complexed with novel synthetic peptide mimetic inhibitor and hirugen |
2
|
27
|
1awfL |
Novel covalent thrombin inhibitor from plant extract |
1
|
26
|
1bmnL |
Human alpha-thrombin complexed with [s-(r*,r*)]-1-(aminoiminomethyl)-n-[[1-[n-[(2-naphthalenylsulfonyl)-l-seryl]-pyrrolidinyl]methyl]-3-piperidenecarboxamide (bms-189090) |
18
|
109
|
1bbrE |
The structure of residues 7-16 of the a alpha chain of human fibrinogen bound to bovine thrombin at 2.3 angstroms resolution |
54
|
259
|
1awhB |
Novel covalent thrombin inhibitor from plant extract |
19
|
150
|
1bbrH |
The structure of residues 7-16 of the a alpha chain of human fibrinogen bound to bovine thrombin at 2.3 angstroms resolution |
53
|
258
|
1bb0B |
Thrombin inhibitors with rigid tripeptidyl aldehydes |
60
|
259
|
1ba8B |
Thrombin inhibitor with a rigid tripeptidyl aldehydes |
55
|
257
|
1bcuH |
Alpha-thrombin complexed with hirugen and proflavin |
53
|
256
|
1b7xB |
Structure of human alpha-thrombin y225i mutant bound to d-phe-pro-arg-chloromethylketone |
63
|
258
|
1bmmH |
Human alpha-thrombin complexed with [s-(r*,r*)]-4-[(aminoiminomethyl)amino]-n-[[1-[3-hydroxy-2-[(2-naphthalenylsulfonyl)amino]-1-oxopropyl]-2-pyrrolidinyl] methyl]butanamide (bms-186282) |
51
|
259
|
1bbrK |
The structure of residues 7-16 of the a alpha chain of human fibrinogen bound to bovine thrombin at 2.3 angstroms resolution |